Astria Therapeutics, Inc.
Astria Therapeutics, Inc. (ATXS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ATXS · as of Jun 8, 2026
Key Statistics
Explore Astria Therapeutics, Inc. Data
atxs stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 8 · Buy rate: 37.5%
The ATXS analyst consensus is Hold, based on ratings from 8 Wall Street analysts over the past 3 months. The average 12-month price target is $19.40, representing +54.21% upside from the current price of $12.58.
Competitors & Peers
atxs competitorsATXS
ARVN
AVBP
DAWN
DNA
ERASStock Performance
Full HistoryAbout Astria Therapeutics, Inc.
Astria Therapeutics, Inc. a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the Unit…
what is astria therapeutics, inc. · atxs stock overview · astria therapeutics, inc. company profile · who is astria therapeutics, inc. ceo · atxs NASDAQ · astria therapeutics, inc. headquarters · astria therapeutics, inc. business segments
About Stock Overview & Key Data
Astria Therapeutics, Inc. (ATXS) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 25, 2015. As of the latest trading session, ATXS stock price is $12.58, with a market capitalization of $718.1M. The stock has returned +92.65% over the past 12 months and -2.40% year-to-date.
According to 8 Wall Street analysts, the consensus rating for Astria Therapeutics, Inc. stock is Hold, with an average 12-month price target of $19.40. In fiscal year 2024, Astria Therapeutics, Inc. reported revenue of — and net income of -$94.3M. For detailed data — including Astria Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Astria Therapeutics, Inc. (ATXS) stock price is $12.58. The stock is traded on NASDAQ under the ticker symbol ATXS. The 52-week range is $3.56 – $13.29.